ATE403441T1 - Bioadhäsive zusammensetzung mit programmierter freisetzung - Google Patents

Bioadhäsive zusammensetzung mit programmierter freisetzung

Info

Publication number
ATE403441T1
ATE403441T1 AT05815499T AT05815499T ATE403441T1 AT E403441 T1 ATE403441 T1 AT E403441T1 AT 05815499 T AT05815499 T AT 05815499T AT 05815499 T AT05815499 T AT 05815499T AT E403441 T1 ATE403441 T1 AT E403441T1
Authority
AT
Austria
Prior art keywords
bio
lecithin
polysaccharide matrix
agent
adhesive
Prior art date
Application number
AT05815499T
Other languages
English (en)
Inventor
Laurence Paris
Original Assignee
Interpharm Dev Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interpharm Dev Sa filed Critical Interpharm Dev Sa
Application granted granted Critical
Publication of ATE403441T1 publication Critical patent/ATE403441T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Adhesive Tapes (AREA)
AT05815499T 2004-10-20 2005-10-19 Bioadhäsive zusammensetzung mit programmierter freisetzung ATE403441T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0411156A FR2876581B1 (fr) 2004-10-20 2004-10-20 Composition bioadhesive a liberation programmee

Publications (1)

Publication Number Publication Date
ATE403441T1 true ATE403441T1 (de) 2008-08-15

Family

ID=34955209

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05815499T ATE403441T1 (de) 2004-10-20 2005-10-19 Bioadhäsive zusammensetzung mit programmierter freisetzung

Country Status (12)

Country Link
US (2) US20080274191A1 (de)
EP (1) EP1807114B1 (de)
JP (1) JP5979466B2 (de)
CN (1) CN101084017B (de)
AT (1) ATE403441T1 (de)
AU (1) AU2005297009A1 (de)
DE (1) DE602005008760D1 (de)
ES (1) ES2314738T3 (de)
FR (1) FR2876581B1 (de)
PL (1) PL1807114T3 (de)
PT (1) PT1807114E (de)
WO (1) WO2006043005A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2876581B1 (fr) * 2004-10-20 2007-05-18 Interpharm Dev Composition bioadhesive a liberation programmee
US20060292102A1 (en) * 2004-12-10 2006-12-28 Roman Stephen B Thixotropic personal lubricant
EP2688551A1 (de) 2011-03-22 2014-01-29 Nordbloom Ltd Zusammensetzung und verfahren
WO2016135219A1 (en) * 2015-02-26 2016-09-01 Fundació Institut D'investigació En Ciències De La Salut Germans Trias I Pujol Topical composition for the treatment of mucosal lesions
WO2021168173A1 (en) * 2020-02-20 2021-08-26 Synkine Therapeutics, Inc. Methods and compositions for treating viral respiratory infections
KR20240109466A (ko) * 2023-01-04 2024-07-11 주식회사 엘지생활건강 치커리 식이섬유 또는 카사바 전분을 포함하는 구강용 제재

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2542616B1 (fr) * 1983-03-17 1987-07-31 Unilever Nv Composition pour le traitement des muqueuses a base d'un antibiotique et d'un hydrocolloide formateur de gel
US4910225A (en) * 1988-01-27 1990-03-20 Senju Pharmaceutical Co., Ltd. Locally administrable therapeutic composition for inflammatory disease
EP0516685A4 (en) * 1990-02-22 1993-03-17 Macnaught Pty. Limited Artificial tears
US5618582A (en) * 1990-07-25 1997-04-08 Vanwinckel; Walter Coating composition and methods of use
CH679670A5 (en) * 1990-10-01 1992-03-31 Applied Pharma Res Commercial carrageenan purificn. - by treatment with hydrogen peroxide in hydrated, inert organic solvent
US5458904A (en) * 1993-10-22 1995-10-17 Zolper; John T. Fat substitutes based on carrageenan gels, processes for producing the same and food products containing the fat substitutes
SE9603480L (sv) 1996-09-23 1998-03-24 Johan Carlfors Beredningsform för svårlösliga läkemedel
CH690814A5 (it) * 1996-11-04 2001-01-31 Applied Pharma Res Composizioni per uso topico contenenti polisaccaridi solfati.
US6159491A (en) * 1999-02-12 2000-12-12 Biovector Technologies, Inc. Prolonged release bioadhesive vaginal gel dosage form
US7064114B2 (en) 1999-03-19 2006-06-20 Parker Hughes Institute Gel-microemulsion formulations
AU3903800A (en) * 1999-03-19 2000-10-09 Parker Hughes Institute Gel-microemulsion formulations
US6482397B1 (en) * 1999-04-20 2002-11-19 Schering-Plough Healthcare Products, Inc. Coloring agent-containing sunless tanning compositions
GB9910212D0 (en) * 1999-05-05 1999-06-30 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
WO2001070271A2 (en) * 2000-03-23 2001-09-27 Collaborative Technologies, Inc. Acid-stable base compositions for preparing surfactant free topical compositions
US20010046526A1 (en) * 2000-04-19 2001-11-29 C-Quest Treatment of fungal infections
AR031135A1 (es) 2000-10-10 2003-09-10 Upjohn Co Composiciones de antibiotico topico para el tratamiento de infecciones oculares
WO2002040056A2 (en) * 2000-11-06 2002-05-23 Alcon, Inc Carrageenan viscoelastics for ocular surgery
JP2002255852A (ja) * 2001-03-01 2002-09-11 Toa Eiyo Ltd 口内炎用スプレー製剤
JP3936324B2 (ja) * 2002-10-11 2007-06-27 持田製薬株式会社 口腔内適用抗真菌剤
US7820145B2 (en) * 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
FR2848473B1 (fr) * 2002-12-16 2008-04-11 Laurence Paris Compositions visqueuses, aqueuses ou hydro-alcooliques, tamponnees ou non, pour la fabrication de capsules molles, et procede de fabrication de films a partir de telles compositions
FR2876581B1 (fr) * 2004-10-20 2007-05-18 Interpharm Dev Composition bioadhesive a liberation programmee

Also Published As

Publication number Publication date
FR2876581A1 (fr) 2006-04-21
AU2005297009A1 (en) 2006-04-27
PL1807114T3 (pl) 2009-05-29
WO2006043005A3 (fr) 2007-04-05
JP5979466B2 (ja) 2016-08-24
WO2006043005A2 (fr) 2006-04-27
CN101084017B (zh) 2012-11-14
US20080274191A1 (en) 2008-11-06
EP1807114B1 (de) 2008-08-06
ES2314738T3 (es) 2009-03-16
JP2008517043A (ja) 2008-05-22
PT1807114E (pt) 2008-11-18
DE602005008760D1 (de) 2008-09-18
FR2876581B1 (fr) 2007-05-18
US10646435B2 (en) 2020-05-12
US20160235715A1 (en) 2016-08-18
CN101084017A (zh) 2007-12-05
EP1807114A2 (de) 2007-07-18

Similar Documents

Publication Publication Date Title
ATE403441T1 (de) Bioadhäsive zusammensetzung mit programmierter freisetzung
WO2005048930A3 (en) Surfactant-based gel as an injectable, sustained drug delivery vehicle
PE20081365A1 (es) Formulaciones topicas para administracion local que contienen indoxacarb
AR048878A1 (es) Composiciones topicas de metadona y metodos para usarlas
WO2004064769A3 (en) Methods for making and using topical delivery agents
WO2008018796A3 (en) Viscoelastic aqueous gels comprising microspheres
ATE373422T1 (de) Mikroemulsionbildende herbizidkonzentrate, mikroemulsionen und verfahren
CY1112950T1 (el) Νηματωδοκτονες συνθεσεις
MX2007004003A (es) Composiciones de amitraz.
WO2006009987A3 (en) Dissolvable film composition
EA200702198A1 (ru) Фармацевтические составы
ATE399847T1 (de) Reinigungsmittel vom typ der multiplen emulsion
ATE464888T1 (de) Vorrichtung für die transdermale abgabe von wirkstoffen
BRPI0709057B8 (pt) veículo mucoso bioadesivo de lenta liberação, método para preparar um veículo mucoso bioadesivo de lenta liberação, e, uso do veículo mucoso bioadesivo de lenta liberação
RS51271B (sr) Čvrsta farmaceutska kompozicija koja sadrži donepezil hidrohlorid
NO20080002L (no) Formuleringer av konjugerte ostrogener og bazedoxifen
NO20083027L (no) Kontrollert frigivelses-fastformpreparat
DE602005018635D1 (de) Polymerzusammensetzung
ATE459338T1 (de) Formulierungen für benzimidazolylpyridylether
EP2023724B8 (de) Synergistische wirkstoffkombinationen
BRPI0309651B8 (pt) método para prevenir ou reduzir a resistência a um pesticida de uma peste de substrato, composição de pesticida, uso dos mesmos, e, método para preparar uma composição de pesticida
BRPI0415566A (pt) agente aglutinante para matriz de solidificação
DK1651274T3 (da) Bioadhæsivt gel på basis af hydroxyethylcellulose
WO2005044001A3 (en) Insecticidal composition with use indicator
BRPI0406734A (pt) Composição termiticida, e, método para controlar térmitas

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties